PCAR
56
3
NWS
69
7
ESS
64
4
BWA
46
2
KMX
64
6
F
47
4
BK
72
4
GM
68
3
IPG
53
4
FITB
60
2
NUE
58
7
AVGO
22
2
CAH
53
6
FLS
75
2
AMAT
42
6
ADI
47
2
HBAN
56
2
UPS
51
10
BRK.B
42
2
CVS
50
2
PCAR
56
3
NWS
69
7
ESS
64
4
BWA
46
2
KMX
64
6
F
47
4
BK
72
4
GM
68
3
IPG
53
4
FITB
60
2
NUE
58
7
AVGO
22
2
CAH
53
6
FLS
75
2
AMAT
42
6
ADI
47
2
HBAN
56
2
UPS
51
10
BRK.B
42
2
CVS
50
2
Financhill
Back

LENZ Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
89

LENZ
LENZ Therapeutics

Last Price:
34.33
Seasonality Move:
-7.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

LENZ Therapeutics Price Quote

$34.33
+0.01 (+1.24%)
(Updated: November 22, 2024 at 5:35 AM ET)

LENZ Therapeutics Key Stats

Buy
89
LENZ Therapeutics (LENZ) is a Buy
Day range:
$33.10 - $34.62
52-week range:
$14.42 - $38.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.38%
Volume:
85.1K
Avg. volume:
165.1K
1-year change:
111.33%
Market cap:
$943.8M
Revenue:
$15M
EPS:
$-5.24

How Much Does LENZ Therapeutics Make?

Data Unavailable

Is LENZ Therapeutics Growing As A Company?

Data Unavailable

LENZ Therapeutics Stock Price Performance

What Is LENZ Therapeutics 52-Week High & Low?

LENZ Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENZ Therapeutics?

  • How Much Debt Does LENZ Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does LENZ Therapeutics Have?
    Cash and short term investments quarterly total is $217.1M
  • What Is LENZ Therapeutics’s Book Value Per Share?
    Book value per share is 7.83

Is LENZ Therapeutics Cash Flow Positive?

  • What Is LENZ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.3M
  • What Is LENZ Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $197M
  • What Is LENZ Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$127.4M

LENZ Therapeutics Return On Invested Capital

Data Unavailable

LENZ Therapeutics Earnings Date & Stock Price

LENZ Therapeutics Competitors

  • Who Are LENZ Therapeutics's Competitors?
    Below is a list of companies who compete with LENZ Therapeutics or are related in some way:
    • Oruka Therapeutics Inc (ORKA)
    • PetMed Express Inc (PETS)
    • R1 RCM Inc (RCM)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LENZ Therapeutics Dividend Yield

LENZ Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.35%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 39.29
Upside from Last Price: 14.47%

Major Shareholders

  • How many LENZ shares are owned by institutional investors?
    29.1M LENZ shares are owned by institutional investors
  • How many LENZ shares are owned by insiders?
    242.8K LENZ shares are owned by insiders